Notable Upgrades: Tesla Motors (TSLA), Avalanche Biotechnologies (AAVL), J. C. Penney (JCP), Kite Pharma (KITE), Mobileye N.V. (MBLY)

Analysts at Morgan Stanley (MS) raised their Tesla Motors, Inc. (TSLA) price target to $465 from $280 in a research report issued to clients on Monday. TSLA is currently printing a higher than average trading volume with the issue trading 4.3 million shares, compared to the average volume of 3.6 million. The stock began trading […] View the full post at: Notable Upgrades: Tesla Motors (TSLA), Avalanche Biotechnologies (AAVL), J. C. Penney (JCP), Kite Pharma (KITE), Mobileye N.V. (MBLY) Related posts: Japan’s Shionogi To Acquire Sciele Pharma (SCRX) for $1.42 Billion Pharma Megamergers: Will They Continue? General Motors Bankruptcy Filing Appears Imminent